High-entropy alloys are promising advanced materials for demanding applications, but discovering useful compositions is difficult and expensive due to the vast number of possible element combinations.

Dr. Andrew Pieper, director of the Brain Health Medicines Center at University Hospitals and senior author of the study, emphasizes this represents a fundamental shift in understanding the disease.

For more than a century, people have considered Alzheimer's disease (AD) an irreversible illness. Consequently, research has focused on preventing or slowing it, rather than recovery. Despite billions ...

Pret Advanced Materials, LLC, a supplier of thermoplastic resins, has announced an expansion of its operations in Florence County, SC. The $18.5M investment will enhance the company's capabilities and ...

A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of ...

Changes in screening recommendations over a decade ago may have inadvertently resulted in later diagnosis of the most common cancer in men, a new study has found. By Roni Caryn Rabin Prostate cancer ...

OpenAI announced a new product within ChatGPT called "study mode" to help students work through problems step by step. Study mode is available to Free, Plus, Pro and Team users, and it's coming to ...

WhatsApp has introduced Advanced Chat Privacy, a feature that builds on its end-to-end encryption to keep your messages as private as possible by keeping chats in the ...

Some ChatGPT subscribers are reporting a new feature appearing in their drop-down list of available tools called “Study Together.” The mode is apparently the chatbot’s way of becoming a better ...

The best thing about studying schools is the people you meet. Twenty years back in Tucson, I met two remarkable leaders, Michael and Olga Block, who created schools combining the high academic ...

The phase II study of pembrolizumab plus lenvatinib for patients with unresectable cutaneous angiosarcoma (Pembro-Lenva for cAS/PLAS trial). A multicenter, randomized, global phase 3 study to assess ...